We are proud to announce the launch of our Psychedelic Access for Veterans Project. There is an urgent need for effective, accessible mental health interventions for veterans, and psychedelic-assisted therapies offer hope for more effective interventions to treat PTSD, depression, and other mental health concerns.

SoundMind Institute is dedicated to educating the public on psychedelic-assisted therapy, and advocating for these life-changing treatments in local and national policy settings. One of the most powerful ways to advocate for these treatments is through sharing the real-life stories of those who have been helped by psychedelic medicine and psychedelic-assisted therapy.

The Solidarity Series is an initiative by SoundMind Project, a nonprofit aimed at providing access to wellness information and therapy to marginalized groups in Philadelphia and beyond. This free monthly speaker lineups took place from June 2020 – June 2021, with a particular focus on mental and cognitive health, alternative medicine, and psychedelics. All donations related to this series went towards providing educational material and psychotherapy to BIPOC (Black, Indigenous, and People of Color), and COVID-19 essential workers in need. Additionally, SoundMind has ongoing scholarships available to BIPOC for educational courses (SoundMind Learning Series) and sliding scale for psychedelic psychotherapy.

SoundMind Is Hiring: Communications and Marketing Specialist (Part-Time, Remote)

Dr. Hannah was recently featured on The Psychedelic Entrepreneur podcast with Beth Weinstein.

June 8, 2022, SoundMind joined the Center for Psychedelic Education, Reason for Hope, and other advocates for safe and affordable psychedelic medicine at Pennsylvania’s capital building in Harrisburg for a day of legislative visits and activism! SoundMind and Dr. Hannah stood side-by-side with other amazing local advocates to raise awareness and provide evidence-based policy recommendations for safe and affordable psychedelic medicine. Thank you everyone for your tireless and invaluable efforts as we progress together in the movement for equitable, affordable access to psychedelic medicine.

Trans-affirming care in the psychedelic space. A Guide for Therapists, Clinicians, Facilitators, and Healers

Friday, June 17, 2022, the Oregon Health Authority approved the SoundMind Institute Psychedelic Facilitator Training program as a state-sanctioned training facility for Oregon Psilocybin Services. We are beyond excited to be one of the first three programs in the world to become approved to offer legal psilocybin training for facilitators.

SoundMind is excited to share this important piece by Dr. Darron T. Smith at The University of Memphis, which features SoundMind Center as an important leader in the space of equitable access to psychedelic medicine.

Watch Hannah McLane, MD, MA, MPH and Elias Dakwar, MD talk about psychedelics for The Shift Network. Integration As Medicine: Ketamine and Beyond.

This is a 12-month training program for clinicians and other professionals that provides a foundational understanding of the literature and practice of psychedelic-assisted psychotherapy, including the use of ketamine, MDMA, and psilocybin in therapeutic settings. This program is designed for clinicians—especially psychotherapists, physicians, and others, but being a clinician is not a requirement for acceptance.

A focus on bridging ceremonial and medical uses of psilocybin

The “journey,” in this instance, is brought on by ketamine, administered intravenously, as a treatment for mental health disorders, albeit one that has not yet been approved by the Food and Drug Administration.

Tripping's not just for deadheads anymore: Philly parents — and lots of other people — are learning that the secret to health, happiness, and healing might just come from some formerly far-out drugs.

Like most working parents, Marissa has a lot to juggle — kids, her job as a nutritionist, her home outside of Philadelphia. And then there are the in-laws.

The Philadelphia Inquirer wrote about SoundMind and interviewed our founder Dr. Hannah McLane. You can read some highlights in this post.

Research into psychedelic-assisted therapy has grown in the past ten years as non-profits, academic institutions, pharmaceutical companies, and even venture capitalists race to develop protocols for using MDMA, psilocybin, ketamine, and other psychedelic substances to treat mental illness. Already, dozens of ketamine clinics across the country administer the medication off-label for depression, and MDMA- and psilocybin-assisted therapy are expected to be approved by the FDA in the coming years.

You’re lying on a bed in a dimly–lit room. Music surrounds you, and the air is soft on your skin. You slip a lozenge under your tongue. As it dissolves, you close your eyes, settling in for the experience ahead. Sitting beside you, a therapist offers a reassuring presence. If anxiety sets in, you’re prepared: deep breath in, then out. Slowly you ease into an altered state of consciousness as visions, memories, and visceral sensations wash over you in waves. Your journey begins.

Read other highlights from the article in this blog post.

This September, SoundMind joined state leaders, community advocates, and other key stakeholders in Lancaster for the PA Latino Convention, an annual gathering focused on championing the needs of the state’s rapidly expanding Latinx community. Pennsylvania’s Latinx population has more than doubled in the last 20 years—to nearly one million residents—and is home to the second largest migration of Puerto Ricans following Hurricane Maria.

The Temple News published an article about SoundMind and Hannah McLane, Temple University alumna. Read some highlights in this post.

Philadelphia Magazine featured SoundMind and our founder Dr. Hannah McLane in a Q&A on psychedelic medicine in Philly! Some highlights from the interview are in the post.